Literature DB >> 341453

Smear-positive and culture-negative results of routine sputum investigations for the detection and therapy control of pulmonary tuberculosis.

J M Domínguez, E S Vivas.   

Abstract

The frequency of smear-positive and culture-negative results (M + C-) is an important factor in the supervision by the Central Laboratory of its own activities and those of the laboratories in the periphery. Under the conditions of the present study, which included evaluation of 6415 specimens positive on smear during 5 years and studied simultaneously by microscopy and culture, about one half of the M+C- results (3% of the total) were thought to be probably laboratory errors and the other half were from patients being treated by chemotherapy. It is necessary to know, at least approximately, the size of this latter group of persons before the contribution of laboratory errors can be estimated and the necessary action taken to reduce their frequency.

Entities:  

Mesh:

Year:  1977        PMID: 341453     DOI: 10.1016/0041-3879(77)90046-0

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  3 in total

1.  Pretreatment sputum smear grade and smear positivity during follow-up of TB patients in Ahmedabad, India.

Authors:  J Patel; P Dave; S Satyanarayana; A M V Kumar; A Shah; R Ananthakrishnan; A Ratnu
Journal:  Public Health Action       Date:  2013-12-21

2.  Number of sputum specimens during treatment follow-up of tuberculosis patients: two or one?

Authors:  R S Kumar; A M V Kumar; M Claassens; V V Banurekha; N S Gomathi; P Venkatesan; S Swaminathan
Journal:  Public Health Action       Date:  2013-12-21

3.  Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.

Authors:  Hyung Koo Kang; Byeong-Ho Jeong; Hyun Lee; Hye Yun Park; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Won-Jung Koh
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.